ATR inhibitors induce cell death in ALT-positive osteosarcoma and glioblastoma cells ATR inhibition may be a useful treatment approach in cancers that use the alternative lengthening of telomeres (ALT) pathway to overcome cell death.…
The Pharmaceutical Journal’s top 5 comment pieces of 2014Benedict Lam takes a look back on the most popular and talked about comment pieces of 2014…
Gold standard guidance on injectable drugs ‘Handbook on injectable drugs, 18th edition’, editor-in-chief Gerald K McEvoy.…
Audit highlights problem of patients taking NSAIDs without gastroprotectionMany patients taking non-steroidal anti-inflammatory drugs are not co-prescribed gastroprotective agents, an audit of community pharmacies in England has found.…
Cancer Drugs Fund has undermined NICE, its chair admits The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies, its chair says.…
Most popular features of 2014 from The Pharmaceutical Journal Using visual representations of data to tell a story is proving popular, with infographic features taking first, second and third place in the top five features of 2014.…
WHO calls for basic medicines to be made available to tackle deaths from non-communicable diseasesJust under half the 38 million deaths in the world from non-communicable diseases could have been prevented, according to the World Health Organization.…
Top 10 learning articles of 2014 from The Pharmaceutical Journal Our response to the Ebola outbreak is a sign of how our learning content is changing to meet your needs.…
FDA advice on metformin is curbing its use Researchers want the US Food and Drug Administration to revisit its advice on the use of metformin in people with higher serum creatinine levels.…
Identifying and managing sarcoidosis Sarcoidosis is a complex immunological disorder that requires careful management and vigilant monitoring.…